← FDA MEDWATCH
FDA (US) · FDA PRESS RELEASEJune 30, 2026
FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
What this record is not
Item details are published by the U.S. FDA on fda.gov; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA. The authoritative notice is on fda.gov.
Item type
FDA Press Release
Published
June 30, 2026
Source
U.S. FDA (MedWatch / press releases)
READ THE FULL FDA NOTICE
The complete FDA notice — the affected products, the action required, and any recall detail — is published on fda.gov. SPEQ surfaces and indexes it for reference; the authoritative notice lives on fda.gov.
View on fda.gov →